Etanercept-Induced Encephalopathy in a 7-Year-Old Child

Ekici B., Aydin K., Cantez S., Ergul Y., Tatli B.

PEDIATRIC NEUROLOGY, vol.45, no.4, pp.271-273, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.1016/j.pediatrneurol.2011.06.013
  • Journal Name: PEDIATRIC NEUROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.271-273
  • Istanbul University Affiliated: Yes

Abstract

Adverse events were reported in various patients treated with etanercept, including infections (sepsis and tuberculosis), malignancies (e.g., lymphoma), demyelinating disorders, and autoimmune diseases. Only two adult patients with etanercept-related encephalopathy were previously reported. We describe a 7-year-old patient who developed encephalopathy immediately after his third dose of etanercept. To the best of our knowledge, ours is the first report of a pediatric patient with a diagnosis of systemic arthritis and who developed etanercept-related encephalopathy. (C) 2011 Elsevier Inc. All rights reserved.